» Authors » Hwa-Sheng Tang

Hwa-Sheng Tang

Explore the profile of Hwa-Sheng Tang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 181
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang H, Chen P, Lung F
Psychiatr Q . 2017 Oct; 89(2):371-381. PMID: 29038990
The aim of this study was to investigate pathway relationship of personality characteristics and alexithymic traits in OCD symptoms of obsession, and compulsive behavior of washing and checking. Two-hundred and...
2.
Lin H, Hsu Y, Liu C, Chen C, Hsiao M, Liu Y, et al.
Int Clin Psychopharmacol . 2013 Jul; 28(6):339-45. PMID: 23881184
This is a single-blind, parallel, flexible-dose study to compare the efficacy and tolerability of escitalopram and paroxetine in the treatment of patients with major depressive disorder. We recruited 399 patients...
3.
Kuo H, Liu S, Tsou H, Liu S, Lin K, Lu S, et al.
Pharmacogenomics . 2013 Jul; 14(10):1191-201. PMID: 23859573
Aim: The liver CYP1A2 enzyme may metabolize antidepressant escitalopram (S-CIT) to S-desmethylcitalopram (S-DCIT) and S-didesmethylcitalopram (S-DDCIT). This study tested whether genetic polymorphisms in the CYP1A2 gene are associated with the...
4.
Chiu C, Lo Y, Tang H, Liu I, Chiang W, Yeh F, et al.
Psychiatry Res . 2011 May; 192(3):176-82. PMID: 21546223
Previous studies have reported white matter abnormalities in patients with obsessive-compulsive disorder (OCD). This study aimed to further explore white matter abnormalities in OCD patients through diffusion spectrum imaging (DSI)...
5.
Wu P, Tang H, Lane H, Tsai C, Tsai G
J Clin Psychopharmacol . 2011 Apr; 31(3):369-74. PMID: 21508860
Background: Several lines of evidence implicate glutamatergic neurotransmission in the pathophysiology of obsessive compulsive disorder (OCD). Sarcosine is an endogenous antagonist of glycine transporter-1. By blocking glycine uptake, sarcosine may...
6.
Lin K, Tsou H, Tsai I, Hsiao M, Hsiao C, Liu C, et al.
Pharmacogenomics . 2010 Dec; 11(11):1535-43. PMID: 21121774
Aim: Paroxetine is a drug of choice in the treatment of major depressive disorder (MDD). Its metabolism has recently been reported to be mediated through the CYP enzymes 1A2 and...
7.
Hung T, Tang H, Chiu C, Chen Y, Chou K, Chiou H, et al.
J Clin Nurs . 2010 Nov; 19(21-22):3092-101. PMID: 21040015
Aims And Objectives: The major aims of this study were to explore the differences in anxiety, depressive symptoms and suicidal ideation between high and low obsessive compulsive symptom groups, as...
8.
Lin K, Chiu Y, Tsai I, Chen C, Shen W, Liu S, et al.
Pharmacogenet Genomics . 2010 Sep; 21(4):163-70. PMID: 20859246
Objective: ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) is a drug transporter protein expressed on the epithelial cells of the intestine and the endothelial cells of the blood-brain barrier....
9.
Tsai M, Lin K, Hsiao M, Shen W, Lu M, Tang H, et al.
Pharmacogenomics . 2010 Mar; 11(4):537-46. PMID: 20350136
Aims: The antidepressant escitalopram (S-CIT) is metabolized by the cytochrome-P450 (CYP) enzymes CYP 2D6, 2C19 and 3A4. This study evaluated the impact of CYP2D6, 2C19 and 3A4 genetic polymorphisms on...
10.
Lee C, Chiu C, Chiu C, Chang C, Tang H
Psychiatry Res . 2009 Aug; 169(2):183-5. PMID: 19647328
Twenty drug-naïve patients with obsessive-compulsive disorder (OCD) were compared with matched controls on their performance of the Continuous Performance Test (CPT). There was no difference on any measure of the...